IRIS Accounts Production v23.1.5.20 07842177 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false 82809 82693 81932 116 877 82809 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh078421772022-03-31078421772023-03-31078421772022-04-012023-03-31078421772021-03-31078421772021-04-012022-03-31078421772022-03-3107842177ns15:EnglandWales2022-04-012023-03-3107842177ns14:PoundSterling2022-04-012023-03-3107842177ns10:Director12022-04-012023-03-3107842177ns10:PrivateLimitedCompanyLtd2022-04-012023-03-3107842177ns10:SmallEntities2022-04-012023-03-3107842177ns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3107842177ns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3107842177ns10:SmallCompaniesRegimeForAccounts2022-04-012023-03-3107842177ns10:FullAccounts2022-04-012023-03-310784217741ns10:Director12022-03-310784217741ns10:Director12021-03-310784217741ns10:Director12022-04-012023-03-310784217741ns10:Director12021-04-012022-03-310784217741ns10:Director12023-03-310784217741ns10:Director12022-03-3107842177ns5:CurrentFinancialInstruments2023-03-3107842177ns5:CurrentFinancialInstruments2022-03-3107842177ns5:Non-currentFinancialInstruments2023-03-3107842177ns5:Non-currentFinancialInstruments2022-03-3107842177ns5:ShareCapital2023-03-3107842177ns5:ShareCapital2022-03-3107842177ns5:RetainedEarningsAccumulatedLosses2023-03-3107842177ns5:RetainedEarningsAccumulatedLosses2022-03-3107842177ns10:RegisteredOffice2022-04-012023-03-3107842177ns5:PlantMachinery2022-03-3107842177ns5:PlantMachinery2022-04-012023-03-3107842177ns5:PlantMachinery2023-03-3107842177ns5:PlantMachinery2022-03-3107842177ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3107842177ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3107842177ns10:Director22022-04-012023-03-3107842177ns10:Director222022-03-3107842177ns10:Director222021-03-3107842177ns10:Director222022-04-012023-03-3107842177ns10:Director222021-04-012022-03-3107842177ns10:Director222023-03-3107842177ns10:Director222022-03-31
REGISTERED NUMBER: 07842177 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 March 2023

for

S K HEALTHCARE LIMITED

S K HEALTHCARE LIMITED (REGISTERED NUMBER: 07842177)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Balance Sheet 1

Notes to the Financial Statements 3


S K HEALTHCARE LIMITED (REGISTERED NUMBER: 07842177)

Balance Sheet
31 March 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 50,346 57,215

CURRENT ASSETS
Stocks 73,345 67,115
Debtors 5 637,113 803,012
Cash at bank and in hand 264,924 136,130
975,382 1,006,257
CREDITORS
Amounts falling due within one year 6 238,517 322,872
NET CURRENT ASSETS 736,865 683,385
TOTAL ASSETS LESS CURRENT
LIABILITIES

787,211

740,600

CREDITORS
Amounts falling due after more than one
year

7

(203,692

)

(203,881

)

PROVISIONS FOR LIABILITIES (10,871 ) (10,871 )
NET ASSETS 572,648 525,848

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 572,548 525,748
SHAREHOLDERS' FUNDS 572,648 525,848

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

S K HEALTHCARE LIMITED (REGISTERED NUMBER: 07842177)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2023 and were signed on its behalf by:





Gurjinder Singh - Director


S K HEALTHCARE LIMITED (REGISTERED NUMBER: 07842177)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

S K Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07842177

Registered office: Unit 13 Radway Industrial Estate
Radway Road
Shirley
Birmingham
West Midlands
B90 4NR

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

S K HEALTHCARE LIMITED (REGISTERED NUMBER: 07842177)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2022 - 10 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022 154,313
Additions 3,195
At 31 March 2023 157,508
DEPRECIATION
At 1 April 2022 97,098
Charge for year 10,064
At 31 March 2023 107,162
NET BOOK VALUE
At 31 March 2023 50,346
At 31 March 2022 57,215

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 161,763 311,789
Other debtors 475,350 491,223
637,113 803,012

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 10,800 -
Trade creditors 176,344 219,710
Taxation and social security 50,623 103,162
Other creditors 750 -
238,517 322,872

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£    £   
Bank loans 202,815 121,072
Other creditors 877 82,809
203,692 203,881

S K HEALTHCARE LIMITED (REGISTERED NUMBER: 07842177)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2023 and 31 March 2022:

2023 2022
£    £   
Amritpal Singh Sandhu and Gurjinder Singh
Balance outstanding at start of year (82,809 ) (82,693 )
Amounts advanced 81,932 -
Amounts repaid - (116 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (877 ) (82,809 )

9. RELATED PARTY DISCLOSURES

The amount owed By GSK (Birmingham) Ltd of £182,624 and the amount owed By A.M.S Healthcare Ltd of £235,573 are both related party transactions